SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 118 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 3.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $489,923 | -35.1% | 126,595 | 0.0% | 0.00% | – |
| Q2 2023 | $754,506 | +98.2% | 126,595 | +8.8% | 0.00% | – |
| Q1 2023 | $380,612 | -10.4% | 116,395 | +8.2% | 0.00% | – |
| Q4 2022 | $425,000 | -34.2% | 107,595 | 0.0% | 0.00% | – |
| Q3 2022 | $646,000 | -6.6% | 107,595 | 0.0% | 0.00% | – |
| Q2 2022 | $692,000 | -19.8% | 107,595 | +3.0% | 0.00% | – |
| Q1 2022 | $863,000 | -46.6% | 104,496 | +0.2% | 0.00% | -100.0% |
| Q4 2021 | $1,615,000 | -30.4% | 104,296 | +1.3% | 0.00% | 0.0% |
| Q3 2021 | $2,319,000 | +299.8% | 102,996 | +249.2% | 0.00% | – |
| Q2 2021 | $580,000 | +26.1% | 29,496 | +114.8% | 0.00% | – |
| Q1 2021 | $460,000 | – | 13,729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |